Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Anti-Inflammatory Agents, Non-Steroidal MeSH Descriptor Data 2025
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Entry Version
NSAID
Entry Term(s)
Analgesics, Anti-Inflammatory
Anti Inflammatory Agents, Nonsteroidal
Antiinflammatory Agents, Non Steroidal
Antiinflammatory Agents, Nonsteroidal
Aspirin-Like Agent
Aspirin-Like Agents
NSAID
NSAIDs
Non-Steroidal Anti-Inflammatory Agent
Non-Steroidal Anti-Inflammatory Agents
Nonsteroidal Anti-Inflammatory Agent
Nonsteroidal Anti-Inflammatory Agents
Registry Numbers
0
NLM Classification #
QV 95
Previous Indexing
Analgesics, Anti-Inflammatory (1966-1986)
Anti-Inflammatory Agents (1966-1986)
Public MeSH Note
87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89
Online Note
use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL to search ANALGESICS, ANTI-INFLAMMATORY 1975-89
History Note
87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.